奥兰zapine 操纵神经活性信号,并可能出现代谢障碍
Pukar Khanal1, Farshid Zargari2,3, Yadu Nandan Dey4
1Department of Pharmacology, NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Nitte (Deemed to be University), Mangalore, India.
Journal of biomolecular structure & dynamics
|July 21, 2023
概括
奥兰沙平是一种抗精神病药物,可以通过破坏多巴胺,血清素和组胺通路来引起体重增加. 这种放松管制影响了参与能量平衡和新陈代谢的关键信号通路.
科学领域:
- 药理学和分子生物学
- 神经科学是一个神经科学.
- 代谢研究研究 代谢研究
背景情况:
- 奥兰沙平是一种广泛处方的非典型抗精神病药物,用于治疗精神疾病.
- 它经常与显著的体重增加和代谢障碍有关,影响患者的坚持和结果.
研究的目的:
- 调查奥兰扎诱导的代谢变化背后的分子机制.
- 为了确定特定的G蛋白结合受体 (GPCR) 和扎所准的信号通路.
主要方法:
- 使用STRING数据库进行功能丰富分析.
- 从SwissTargetPrediction,DIGEP-Pred和BindingDB.的蛋白质 - 连接物结合亲和力预测和检索.
- 对GPCR-奥兰扎相互作用的同质模型,分子对接和分子动力学 (MD) 模拟.
- 基因和基因组的京都百科全书 (KEGG) 途径分析.
主要成果:
- 奥兰zapine主要向G蛋白结合受体,包括多巴胺,血清素,肌肉蛋白和组胺受体.
- 丰富分析揭示了分子功能,生物过程和细胞组件的共同点,包括KEGG通路.
- 奥兰沙平显著影响神经递质突触和神经活性信号传递.
- 在食中心对多巴胺,血清素,肌肉蛋白和组胺突触的放松调节,以及cGMP-PKG,cAMP和PI3K-Akt信号通路,与体重增加和代谢变化有关.
结论:
- 奥兰扎诱导的体重增加和代谢障碍很可能是由多个神经递质系统的干扰引起的.
- 针对特定的GPCRs和相关的信号通路提供了减轻奥兰zapine副作用的潜在途径.
更多相关视频
相关概念视频
Mania and Antimanic Drugs: Overview
248
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
248
Psychosis: Goals of Pharmacotherapy
168
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
168
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Antipsychotic Drugs: Typical and Atypical Agents
256
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
256
Antipsychotic Drugs: Therapeutic Uses and Side Effects
266
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
266
Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275


